INS and type 2 diabetes mellitus: It is also noteworthy that improved MAM integrity may lead to increased insulin sensitivity, while hypoglycemic treatment is associated with improved ER–mitochondria contacts, which indicates that MAM has potential a therapeutic target for T2DM treatment.